Cargando…

P514: TREATMENT PATTERNS AND REAL-WORLD OUTCOMES OF MOLECULAR SUBGROUPS IN PATIENTS WITH ACUTE MYELOID LEUKEMIA RECEIVING FRONTLINE VENETOCLAX-BASED THERAPY

Detalles Bibliográficos
Autores principales: Lachowiez, Curtis, Zettler, Christina, Barcellos, Anna, Belli, Andrew, Fernandes, Laura, Hansen, Eric, Wang, Ching-Kun, Swords, Ronan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429742/
http://dx.doi.org/10.1097/01.HS9.0000968964.32175.7d
_version_ 1785090787629858816
author Lachowiez, Curtis
Zettler, Christina
Barcellos, Anna
Belli, Andrew
Fernandes, Laura
Hansen, Eric
Wang, Ching-Kun
Swords, Ronan
author_facet Lachowiez, Curtis
Zettler, Christina
Barcellos, Anna
Belli, Andrew
Fernandes, Laura
Hansen, Eric
Wang, Ching-Kun
Swords, Ronan
author_sort Lachowiez, Curtis
collection PubMed
description
format Online
Article
Text
id pubmed-10429742
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-104297422023-08-17 P514: TREATMENT PATTERNS AND REAL-WORLD OUTCOMES OF MOLECULAR SUBGROUPS IN PATIENTS WITH ACUTE MYELOID LEUKEMIA RECEIVING FRONTLINE VENETOCLAX-BASED THERAPY Lachowiez, Curtis Zettler, Christina Barcellos, Anna Belli, Andrew Fernandes, Laura Hansen, Eric Wang, Ching-Kun Swords, Ronan Hemasphere Posters Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10429742/ http://dx.doi.org/10.1097/01.HS9.0000968964.32175.7d Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially.
spellingShingle Posters
Lachowiez, Curtis
Zettler, Christina
Barcellos, Anna
Belli, Andrew
Fernandes, Laura
Hansen, Eric
Wang, Ching-Kun
Swords, Ronan
P514: TREATMENT PATTERNS AND REAL-WORLD OUTCOMES OF MOLECULAR SUBGROUPS IN PATIENTS WITH ACUTE MYELOID LEUKEMIA RECEIVING FRONTLINE VENETOCLAX-BASED THERAPY
title P514: TREATMENT PATTERNS AND REAL-WORLD OUTCOMES OF MOLECULAR SUBGROUPS IN PATIENTS WITH ACUTE MYELOID LEUKEMIA RECEIVING FRONTLINE VENETOCLAX-BASED THERAPY
title_full P514: TREATMENT PATTERNS AND REAL-WORLD OUTCOMES OF MOLECULAR SUBGROUPS IN PATIENTS WITH ACUTE MYELOID LEUKEMIA RECEIVING FRONTLINE VENETOCLAX-BASED THERAPY
title_fullStr P514: TREATMENT PATTERNS AND REAL-WORLD OUTCOMES OF MOLECULAR SUBGROUPS IN PATIENTS WITH ACUTE MYELOID LEUKEMIA RECEIVING FRONTLINE VENETOCLAX-BASED THERAPY
title_full_unstemmed P514: TREATMENT PATTERNS AND REAL-WORLD OUTCOMES OF MOLECULAR SUBGROUPS IN PATIENTS WITH ACUTE MYELOID LEUKEMIA RECEIVING FRONTLINE VENETOCLAX-BASED THERAPY
title_short P514: TREATMENT PATTERNS AND REAL-WORLD OUTCOMES OF MOLECULAR SUBGROUPS IN PATIENTS WITH ACUTE MYELOID LEUKEMIA RECEIVING FRONTLINE VENETOCLAX-BASED THERAPY
title_sort p514: treatment patterns and real-world outcomes of molecular subgroups in patients with acute myeloid leukemia receiving frontline venetoclax-based therapy
topic Posters
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429742/
http://dx.doi.org/10.1097/01.HS9.0000968964.32175.7d
work_keys_str_mv AT lachowiezcurtis p514treatmentpatternsandrealworldoutcomesofmolecularsubgroupsinpatientswithacutemyeloidleukemiareceivingfrontlinevenetoclaxbasedtherapy
AT zettlerchristina p514treatmentpatternsandrealworldoutcomesofmolecularsubgroupsinpatientswithacutemyeloidleukemiareceivingfrontlinevenetoclaxbasedtherapy
AT barcellosanna p514treatmentpatternsandrealworldoutcomesofmolecularsubgroupsinpatientswithacutemyeloidleukemiareceivingfrontlinevenetoclaxbasedtherapy
AT belliandrew p514treatmentpatternsandrealworldoutcomesofmolecularsubgroupsinpatientswithacutemyeloidleukemiareceivingfrontlinevenetoclaxbasedtherapy
AT fernandeslaura p514treatmentpatternsandrealworldoutcomesofmolecularsubgroupsinpatientswithacutemyeloidleukemiareceivingfrontlinevenetoclaxbasedtherapy
AT hanseneric p514treatmentpatternsandrealworldoutcomesofmolecularsubgroupsinpatientswithacutemyeloidleukemiareceivingfrontlinevenetoclaxbasedtherapy
AT wangchingkun p514treatmentpatternsandrealworldoutcomesofmolecularsubgroupsinpatientswithacutemyeloidleukemiareceivingfrontlinevenetoclaxbasedtherapy
AT swordsronan p514treatmentpatternsandrealworldoutcomesofmolecularsubgroupsinpatientswithacutemyeloidleukemiareceivingfrontlinevenetoclaxbasedtherapy